ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

SALT LAKE CITY, Utah, May 22, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced ceramics for medical device and other technical applications, announced the issuance of International Patent No. 7635292, which covers novel agricultural uses of the Company’s silicon nitride (Si₃N₄) particularly in plant protection and antimicrobial treatment. This patent, combined with issued U.S. Patent No. 11,591,217, creates a family of patents focused on addressing the antimicrobial agribiotech market.

SINTX remains focused on advancing silicon nitride technologies for medical applications; however, the material’s broad utility allows for selective expansion into high-impact adjacent sectors. In line with this strategic expansion, the Company has formed a wholly-owned subsidiary that will have a dedicated management team focused on developing and commercializing agricultural and environmental technologies—signaling the official launch of SINTX Agribiotech, Inc.

Market Opportunity
The global antimicrobial fertilizer and crop protection market is projected to grow significantly, reaching up to $10.36 billion by 2030. SINTX intends to position its Si₃N₄ technology at the intersection of sustainability and high-performance crop protection within an industry increasingly focused on sustainable, eco-friendly solutions.

Independent Path for Growth
The new agribiotech subsidiary will operate independently from SINTX’s medical device business, with its own development pipeline. This separation allows for focused resource allocation, technology validation in field settings, and potential partnerships or licensing opportunities with agricultural companies.

“This is more than diversification—it’s about unlocking the full potential of our core material,” said Eric Olson. “We’re establishing a clear path to deploy our Si₃N₄ into vineyards, orchards, farmlands and hydroponic facilities, potentially beginning with one of the most compelling use cases: wine production.”

Silicon Nitride: A Natural Defense Against Crop Disease
Internal research previously published in Frontiers in Microbiology demonstrates that silicon nitride provides powerful antifungal protection against Plasmopara viticola, the pathogen responsible for grapevine downy mildew, one of the most devastating diseases affecting vineyards globally. The study demonstrated that treating grapevine varieties such as Cabernet Sauvignon and Cannonau with Si₃N₄ reduced the growth and sporulation of P. viticola by 80–90%, with complete protection observed in select trials.

Unlike traditional fungicides, SINTX’s Si₃N₄ formulation offers broad-spectrum antimicrobial action without damaging plant tissue or the surrounding environment—especially relevant as copper-based fungicides face increasing regulatory restrictions. (see: Frontiers in Microbiology, 2021)

“Silicon nitride doesn’t just inactivate pathogens—it can also prevent most infections altogether,” said Eric Olson, Chairman and CEO of SINTX. “In our recent studies, silicon nitride exhibited no phytotoxicity, helped buffer environmental pH, and showed no evidence of cytotoxicity in humans. It’s a sustainable, high-performance alternative to copper and chemical-based treatments in viticulture.”

For more information about SINTX Agribiotech or silicon nitride applications in medical or agriculture applications, please visit www.sintx.com.

About SINTX Technologies, Inc.
Located in Salt Lake City, Utah, SINTX Technologies is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans since 2008. Over the past several years, SINTX has utilized strategic acquisitions and alliances to enter new markets. For more information on SINTX Technologies or its materials platform, visit www.sintx.com.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (“PSLRA”) that are subject to a number of risks and uncertainties. Forward-looking statements can be identified by words such as: "anticipate," "believe," "project," "estimate," "expect," "strategy,” "future," "likely," "may," "should," "will" and similar references to future periods.

Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management’s current estimates, projections, expectations and beliefs. Forward looking statements include our belief that Si₃N₄ will be a sustainable, high-performance alternative to copper and chemical-based treatments in viticulture, our ability to position silicon nitride technology at the intersection of sustainability and high-performance crop protection , and our ability to eventually develop an effective crop protection product and successfully market such a product. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, difficulty in commercializing ceramic technologies and development of new product opportunities. A discussion of other risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements can be found in SINTX’s Risk Factors disclosure in its Annual Report on Form 10-K, filed with the SEC on March 19, 2025, and in SINTX’s other filings with the SEC. SINTX undertakes no obligation to publicly revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report, except as required by law.

Business and Media Inquiries for SINTX:
SINTX Technologies
801.839.3502
IR@sintx.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.